WASHINGTON (AP) — The Food and Drug Administration said Friday it approved a new blood cancer drug from Onyx Pharmaceuticals Inc. for patients with advanced disease who have not responded to at least ...
Feb 2 (Reuters) - Onyx Pharmaceuticals Inc said it reached an agreement with the U.S. Food and Drug Administration on the design of the late-stage trial of its blood cancer drug. The company said the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results